342 related articles for article (PubMed ID: 9806104)
1. Recommended drug treatment strategies for the alcoholic patient.
Schaffer A; Naranjo CA
Drugs; 1998 Oct; 56(4):571-85. PubMed ID: 9806104
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of alcohol dependence: a review of the clinical data.
Mann K
CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
[TBL] [Abstract][Full Text] [Related]
3. Current progress in pharmacologic treatment strategies for alcohol dependence.
Clapp P
Expert Rev Clin Pharmacol; 2012 Jul; 5(4):427-35. PubMed ID: 22943122
[TBL] [Abstract][Full Text] [Related]
4. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
Wilde MI; Wagstaff AJ
Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
[TBL] [Abstract][Full Text] [Related]
6. An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence.
Johnson BA
Expert Opin Pharmacother; 2004 Sep; 5(9):1943-55. PubMed ID: 15330732
[TBL] [Abstract][Full Text] [Related]
7. Advances in development of medications for alcoholism treatment.
Litten RZ; Allen JP
Psychopharmacology (Berl); 1998 Sep; 139(1-2):20-33. PubMed ID: 9768539
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacotherapy of substance dependence and withdrawal syndromes].
Walter M; Wiesbeck GA
Ther Umsch; 2009 Jun; 66(6):449-57. PubMed ID: 19496041
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological approaches to the management of alcohol addiction.
Addolorato G; Armuzzi A; Gasbarrini G; De Lorenzi G; Ancona C; Abenavoli L; Parente A; Leggio L; Capristo E; Greco AV; Janiri L; Pozzi G; Taranto C; Caputo F; Bernardi M; Stefanini GF; Foschi FG;
Eur Rev Med Pharmacol Sci; 2002; 6(5):89-97. PubMed ID: 12776801
[TBL] [Abstract][Full Text] [Related]
10. The pharmacological treatment of alcohol dependence: needs and possibilities.
Mann K
Alcohol Alcohol Suppl; 1996 Mar; 31(1):55-8. PubMed ID: 9845038
[TBL] [Abstract][Full Text] [Related]
11. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
12. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
Soyka M; Preuss U; Schuetz C
Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
[TBL] [Abstract][Full Text] [Related]
13. Medications and alcohol craving.
Swift RM
Alcohol Res Health; 1999; 23(3):207-13. PubMed ID: 10890816
[TBL] [Abstract][Full Text] [Related]
14. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
[TBL] [Abstract][Full Text] [Related]
15. Combining psychosocial treatment with pharmacotherapy for alcohol dependence.
Weiss RD; Kueppenbender KD
J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S37-42. PubMed ID: 17114954
[TBL] [Abstract][Full Text] [Related]
16. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.
Lejoyeux M; Lehert P
Alcohol Alcohol; 2011; 46(1):61-7. PubMed ID: 21118900
[TBL] [Abstract][Full Text] [Related]
17. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
Buri C; Moggi F; Giovanoli A; Strik W
Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
[TBL] [Abstract][Full Text] [Related]
18. Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial.
Prisciandaro JJ; Brown DG; Brady KT; Tolliver BK
Psychiatry Res; 2011 Aug; 188(3):361-5. PubMed ID: 21641663
[TBL] [Abstract][Full Text] [Related]
19. Medications for treating alcohol dependence.
Williams SH
Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039
[TBL] [Abstract][Full Text] [Related]
20. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
Rösner S; Leucht S; Lehert P; Soyka M
J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
